pNPS-DHA is an orally active docosahexaenoylethanolamide (DHEA) derivative with anti-allergic activity; it inhibits IgE-dependent passive cutaneous anaphylaxis (PCA) in mice and exhibits anti-degranulation activity in RBL-2H3 mast cells with an IC50 of 15 μM.